Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
Stephanos J. Hadziyannis(National and Kapodistrian University of Athens), Steven L. Chuck(Gilead Sciences (United States)), Katyna Borroto–Esoda(Gilead Sciences (United States)), Patrick Marcellin(Inserm), Zachary Goodman(Inova Fairfax Hospital), Sarah Arterburn(Gilead Sciences (United States)), Jia Ma(Gilead Sciences (United States)), Mario Rizzetto(Fondazione Ricerca Molinette), E. Jenny Heathcote(Toronto Western Hospital), G. Kitis(G. Papanikolaou General Hospital), Nicolaos C. Tassopoulos(Metropolitan Hospital), Carol Brosgart(Gilead Sciences (United States)), Ting‐Tsung Chang(National Cheng Kung University Hospital), Seng Gee Lim(National University of Singapore)
Cited by 882
Related Papers
Liver biopsy†
|Hepatology|2008|1.9k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
|The Lancet|1989|1.2k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
|New England Journal of Medicine|2004|1.1k